CAT25 is a mononucleotide marker to identify HNPCC patients

Journal of Molecular Diagnostics

Volumn 11, Issue 3, 2009, Pages 248-252

  Bianchi, Francesca ^a   Galizia, Eva ^a   Catalani, Romina ^a   Belvederesi, Laura ^a   Ferretti, Concetta ^a   Corradini, Fabio ^a   Cellerino, Riccardo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAT25 MONONUCLEOTIDE; MOLECULAR MARKER; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG; NUCLEOTIDE; TUMOR MARKER;

ALLELE; ARTICLE; BLOOD DONOR; CANCER DIAGNOSIS; COLORECTAL CANCER; EVALUATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; NATIONAL HEALTH ORGANIZATION; RELIABILITY; SAMPLING; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC MARKER; GENETICS;

ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC MARKERS; HUMANS; MICROSATELLITE INSTABILITY; NUCLEOTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 67149084993     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.080155     Document Type: Article

References (21)

1. Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999, 36:801-818
2. Kolodner RD, Marsischky GT: Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999, 9:89-96
3. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993, 71:677-685
4. Merg A, Lynch HT, Lynch JF, Howe JR: Hereditary colon cancer-part I. Curr Probl Surg 2005, 42:195-256
5. Merg A, Lynch HT, Lynch JF, Howe JR: Hereditary colon cancer-part II. Curr Probl Surg 2005, 42:267-333
6. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004, 4:769-80
7. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR: Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812-816
8. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-5257
9. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003, 349:247-257
10. Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR: Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004, 126:394-401
11. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R, Halling KC: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996, 56:4836-4840
12. Pedroni M, Roncari B, Maffei S, Losi L, Scarselli A, Di Gregorio C, Marino M, Roncucci L, Benatti P, Ponti G, Rossi G, Menigatti M, Viel A, Genuardi M, de Leon MP: A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Dis Markers 2007, 23:179-187
13. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261-268
14. Findeisen P, Kloor M, Merx S, Sutter C, Woerner SM, Dostmann N, Benner A, Dondog B, Pawlita M, Dippold W, Wagner R, Gebert J, von Knebel Doeberitz M: T25 repeat in the 3′ untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005, 65:8072-8078
15. Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R: Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers 2004, 20:251-257
16. Wong YF, Cheung TH, Lo KW, Yim SF, Chan LK, Buhard O, Duval A, Chung TK, Hamelin R: Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers. Carcinogenesis 2006, 27:951-955
17. Xicola RM, Llor X, Pons E, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Duque JM, Nicolás-Pérez D, Garcia AM, Rigau J, Gassull MA: Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 2007, 99:244-252
18. Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, Megid WM, Thibodeau SN: Development of a fluorescent multiplex assay for detection of MSI-high tumors. Dis Markers 2004, 20:237-250
19. Pyatt R, Chadwick RB, Johnson CK, Adebamowo C, de la Chapelle A, Prior TW: Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing. Am J Pathol 1999, 155:349-353
20. Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K, Seruca R, Iacopetta B, Hamelin R: Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002, 123:1804-1811
21. Deschoolmeester V, Baay M, Wuyts W, Van Marck E, Van Damme N, Vermeulen P, Lukaszuk K, Lardon F, Vermorken JBM, Wuyts W: Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers. J Mol Diagn 2008, 10:154-159